Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Apr;50(4):1478-9.
doi: 10.1128/JCM.05966-11. Epub 2012 Jan 25.

Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India

Krishna Pandey  1 , V N R Das, Dharmendra Singh, Sushmita Das, C S Lal, N Verma, S Bimal, R K Topno, N A Siddiqui, R B Verma, P K Sinha, Pradeep Das
Affiliations
Case Reports

Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India

Krishna Pandey et al. J Clin Microbiol. 2012 Apr.

Abstract

Post kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that usually develops after treatment of visceral leishmaniasis (VL), a major public health problem in India. The diagnosis and management of PKDL is complex. This is the first case report from India in which PKDL occurred after paromomycin treatment for VL in an Indian patient.

PubMed Disclaimer

References

    1. Das VNR, et al. 2009. Development of post kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis. Am. J. Trop. Med. Hyg. 80:336–338 - PubMed
    1. Dutta M, Ghosh TK. 1983. Review of current status of leishmaniasis epidemiology, p 97–102 Proceedings of the Indo-UK Workshop on Leishmaniasis Indian Council of Medical Research, New Delhi, India
    1. Salotra P, et al. 2001. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis. J. Clin. Microbiol. 39:849–854 - PMC - PubMed
    1. Singh S, Sundar S. 1995. Treatment of post-kala-azar dermal leishmaniasis. Int. J. Dermatol. 34:668–669 - PubMed
    1. Singh SP, et al. 2011. Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS 5:e960 - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources